Karolis Šablauskas

Karolis Šablauskas has a diverse work experience. Karolis started their career in 2015 as a Team Instructor at iGEM "Vilnius-Lithuania" and later served as the Chairman of the Board at Lithuanian Junior Doctors from February 2018 to October 2019. In October 2016, they joined Eli Lilly and Company as a Business Unit Coordinator until January 2018. From January 2018 to July 2020, Karolis worked as a Senior Specialist at VUL Santaros klinikos and concurrently pursued clinical genetics residency from July 2017 to October 2019. In October 2019, they joined Radboudumc as a Researcher, holding the position until July 2020. Karolis then became a Hematology Resident at the Hematology, Oncology, and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos in July 2020. Currently, since March 2019, Karolis is working as a Technical Lead at Ligence.

Karolis Šablauskas completed their Master's degree in Medicine from Vilnius University, which they attended from 2011 to 2017. Before that, there is no available information on their educational background. Additionally, they obtained a certification in Neural Networks and Deep Learning from Coursera in January 2018.